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The  abuse  of  methylenedioxymethamphetamine  (MDMA)  during  pregnancy  is  of  concern.
MDMA  treatment  of rats  during  a period  of  brain  growth  analogous  to  late human  gestation
leads to  neurochemical  and  behavioral  changes.  MDMA  from  postnatal  day  (P)11–20  in  rats
produces reductions  in  serotonin  and  deﬁcits  in spatial  and  route-based  navigation.  In  this
experiment  we  examined  the  impact  of  MDMA  from  P11  to  P20  (20  mg/kg  twice  daily,  8 h
apart) on  neuronal  architecture.  Golgi  impregnated  sections  showed  signiﬁcant  changes.
In the  nucleus  accumbens,  the dendrites  were  shorter  with  fewer  spines,  whereas  in the
dentate  gyrus  the  dendritic  length  was  decreased  but with  more  spines,  and  for  the  entorhi-olgi–Cox staining
entate  gyrus
ntorhinal cortex
nal cortex,  reductions  in  basilar  and  apical  dendritic  lengths  in  MDMA  animals  compared
with  saline  animals  were  seen.  The  data  show  that  neuronal  cytoarchitectural  changes  are
long-lasting  following  developmental  MDMA  exposure  and  are  in  regions  consistent  with
the learning  and  memory  deﬁcits  observed  in  such  animals.
s.  Publ
Y-NC-N© 2014  The  Author
the CC  B
. Introduction
(±)-3,4-Methylenedioxymethamphetamine (MDMA)
an  alter neurotransmitter and hormonal systems [1]
s  well as impair cognitive function among users. These
ognitive changes in users can occur not only during
he period of drug ingestion but for protracted periods
hereafter [2–7]. Worldwide, the largest demographic to
Abbreviations: 5-HT, serotonin; ANOVA, analysis of variance; CWM,
incinnati water maze; DG, dentate gyrus; EC, entorhinal cortex; MDMA,
ethylenedioxymethamphetamine; MWM,  Morris water maze; NAcc,
ucleus accumbens; P, postnatal day; SAL, saline.
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icenses/by-nc-nd/3.0/).ished  by  Elsevier  Ireland  Ltd. This  is  an  open  access  article  under
D  license  (http://creativecommons.org/licenses/by-nc-nd/3.0/).
abuse MDMA  is young adults of reproductive age [8,9].
Those who  take MDMA  may  be at risk for unintended
pregnancy [10–14]. In consideration of the negative
effects produced by MDMA  in adults, there is concern that
fetal  exposure to MDMA  may  adversely affect children’s
physical and/or cognitive development. Nonetheless, few
human  studies have been undertaken to examine the
impact of MDMA  during gestation on neurodevelopmental
outcomes, even though such exposures are known to
occur  [12,15–17], as MDMA  easily crosses the placenta
[18]. Most studies have examined children only within
the  perinatal period for physical abnormalities and not for
cognitive  function [16,17]. A newer study examined early
mental  development following prenatal MDMA  exposure
and  found the amount of drug exposure predicted poorer
outcomes when the children were assessed within their
ﬁrst  year of life [19]. Another substituted amphetamine
cess article under the CC BY-NC-ND license (http://creativecommons.org/
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of abuse, methamphetamine, has been shown to result in
deﬁcits  in cognitive function, motoric performance at 1
year,  and volumetric and physiological changes to regions
of  the brain in children following gestational exposure
[20–24]. As MDMA  demonstrates different effects on
neurotransmitter and hormonal systems when compared
with  methamphetamine, it is unknown whether similar
changes occur in children exposed in utero to MDMA.
In  rats it has been shown that MDMA  exposure, during
a  period of brain development similar to late gestational
human in utero brain development [25], produces cog-
nitive  deﬁcits in the Morris water maze (MWM),  a test
of  spatial learning and memory and the Cincinnati water
maze  (CWM), a test of egocentric route-based learning
[26–32]. These effects are not the result of MDMA-induced
body weight reductions, injection stress, or changes in
maternal care [32]. Furthermore, the deﬁcits emerge early
and  for spatial learning are evident for at least a year
[28]. Interestingly, some of these effects may  be depend-
ent  upon the pattern of drug administration [31]. The
underlying mechanisms for these changes, however, are
not  known. There is evidence that this exposure (postnatal
days (P)11–20) causes reductions in monoamines during
both  the neonatal period and in adulthood [26,33–36]. Fur-
ther,  neonatally MDMA-exposed animals have reductions
in  cAMP-dependent protein kinase A activity and altered
5-HT1A receptor activation when assessed in adulthood
[33]. It is not known whether these biochemical effects
are  accompanied by neuroanatomical changes in regions
important for spatial learning or egocentric learning.
Spatial learning in the MWM  requires a properly
functioning hippocampus [37] and related regions that par-
ticipate  in allocentric mapping (e.g., [38]). Route-based
learning, on the other hand, requires primarily non-
hippocampal regions, including the entorhinal cortex (EC),
dorsal  striatum, and presubiculum [39–41]. The purpose
of  this experiment was to investigate whether long-term
changes in the cytoarchitecture of brain regions important
in  learning, memory, and reinforcement occur after a dos-
ing  regimen of MDMA  that is known to induce learning
and memory deﬁcits. The nucleus accumbens (NAcc) was
included  since we and others showed this to be a vulnera-
ble  area to amphetamines [42–44], and data showing that
the  NAcc can affect both spatial and egocentric learning and
memory  [45–49]. Doses were selected to be comparable to
human  prenatal exposure based on an interspecies expo-
sure  scaling algorithm (reviewed in [29]). Because we have
shown  that a number of control procedures such as injec-
tion  stress and body weight reductions do not play a role
in  the long-lasting learning and memory deﬁcits follow-
ing  MDMA  [32], we limited comparisons to MDMA and the
vehicle-treated saline controls and did not include unin-
jected  controls.
2.  Material and methods
2.1.  SubjectsPrior to experimentation, all procedures were approved
by  the Cincinnati Children’s Research Foundation’s Institu-
tional  Animal Care and Use Committee and all efforts wereeports 1 (2014) 699–706
taken  to minimize discomfort and/or pain and conformed
to  the National Institutes of Health guidelines for animal
use.  The vivarium was fully accredited by the Association
for the Assessment and Accreditation of Laboratory Animal
Care.  The vivarium was  maintained on a 14 h light/10 h dark
cycle  (lights on at 600 h) and food and water were freely
available. Nulliparous female and male Sprague–Dawley
CD International Genetic Standard rats (Charles River Lab-
oratories,  Raleigh, NC) were mated in hanging wire cages
following an acclimation period to the vivarium of at least
1  week. The day a sperm plug was detected was consid-
ered embryonic day 0. Fourteen days after being placed
with  the males, females were transferred to polycarbonate
cages (46 cm × 24 cm × 20 cm)  with woodchip bedding. The
day  of birth was considered P0 and on P1 litters were stan-
dardized to 8 pups balanced for 4 males and 4 females to
the  extent possible. Offspring were weighed weekly and
uniquely identiﬁed by an ear punch on P11. The offspring
were the subjects for these experiments and were ran-
domly selected for inclusion using a random numbers table.
Lab  personal were blind to treatment group assignment.
2.2. (±)-3,4-Methylenedioxymethamphetamine
treatment
(±)-3,4-Methylenedioxymethamphetamine HCl
(expressed as the freebase and greater than 95% pure)
was  obtained from the National Institute on Drug Abuse
through its provider Research Triangle Institute (Research
Triangle Park, NC). MDMA  was  dissolved in sterile iso-
tonic  saline (SAL) at a concentration of 20 mg/3 ml  and
administered to animals at a dose of 20 mg/kg through a
subcutaneous route in the dorsum. MDMA  was delivered
twice daily from P11 to P20 with an 8 h interval between
treatments. Irritation to the dermis was minimized by
varying  injection sites. Prior to each injection, animals
were weighed. Animals were weaned naturally by their
dams  [50,51] and separated on P28 and housed in pairs. A
total  of six litters were prepared for this study and only a
single  pair of males (1 MDMA-treated and 1 SAL-treated)
was  used from each litter in a split-litter design.
2.3. Golgi–Cox analysis
On  approximately P60 (a day that is encompassed by
our  previous behavioral testing periods, see [29]) the ani-
mals  were given an overdose of sodium pentobarbital and
perfused  intracardially with physiological saline using a
Masterﬂex pump (Cole Palmer, Vernon Hills, IL). Litter-
mates (i.e., 1 MDMA  and 1 SAL animal) were perfused
simultaneously and following 10 min  of perfusion, whole
brains  were removed. Brains were placed in Golgi–Cox
solution for 14 days and subsequently in a Golgi–Cox/30%
sucrose solution for 3 days. The tissues were cut in 200 m
sections  using a vibratome, and sections were mounted on
gelatinized  slides and stained using the method described
previously [52]. Neurons were identiﬁed at a lower magni-
ﬁcation (100×) in each hemisphere and then ﬁve neurons
per hemisphere in each region of interest were traced at
a  higher magniﬁcation (250×) using the camera lucida
method. An experimenter, blinded to treatment, performed
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he cell selection and tracings. In order for a neuron to be
elected  it had to have a dendritic tree that was well visu-
lized  and not obscured by stain precipitate, blood vessels,
r  astrocytes. If more than ﬁve neurons were identiﬁed
n each hemisphere as reaching these criteria, then the
ells  included were randomly selected from the total num-
er  of cells identiﬁed. Four brain areas were traced and
uantiﬁed, these were as follows: EC (Layer II), nucleus
ccumbens shell (NAcc), and the dentate gyrus (DG), and
nly  dendritic lengths were examined in Layer V of the
edial  frontal cortex (Zilles Cg3). Pyramidal cells were
raced in the cortical regions, granule cells in the DG,
nd  medium spiny neurons in the NAcc. These regions
ere selected based on the behavioral phenotype that
nimals display following exposure to MDMA  during the
ame  neonatal period as used here, namely impairments
n spatial learning and route-based egocentric learning
26–28,31,32].
Dendritic length was quantiﬁed using a Sholl analysis
f  ring intersections [53]. For example, to obtain a mea-
ure  of length and complexity, the total number of ring
ntersections was summed and then averaged across cells.
pine  density was quantiﬁed by counting spines on one
ourth-order terminal tip from basilar dendrites and one
hird-order terminal tip from apical dendrites in the cortex.
hese  regions of the dendrites were used for analysis since
his  is typically where differences have been observed in
ast  studies following psychostimulant administration in
dult  and developing rats [43,44,54]. Secondly, when there
re  increases in dendritic length it most often occurs in
he  distal end, thus, increasing the likelihood of changes
n  dendritic spine densities at this location. Neither NAcc
or  DG neurons have apical and basilar dendritic trees,
herefore, spine density was quantiﬁed using a third-order
erminal tip in these regions. Spine density was  consis-
ently performed on the same branch order and counted
s  the number of spines/10 m of the dendritic branch.
he magniﬁcation factor for the analysis of spine density
as  1000×. The morphological analyses were performed
y personnel blind to the treatment group of the animals.
.4.  Statistics
Because litter effects are an important source of vari-
nce in developmental studies [55], data were analyzed
sing a mixed general linear model analysis of variance
ANOVA; SAS 9.1 Proc Mixed, Cary, NC). In this model,
itter was a blocking factor. For some brain regions, neu-
ons  were either not stained completely or no staining was
resent  and therefore the number of animals represented
as 4–6/treatment. With litter accounted for in the block
actor, treatment was a between factor and hemisphere
as a repeated measure factor. Signiﬁcant interactions
ere analyzed using t-tests generated by Proc Mixed. Proc
ixed  provides adjusted degrees of freedom using the
enward–Roger method. Speciﬁc regions were analyzed
eparately as were basilar and apical dendritic trees. Data
re  presented as mean ± SEM and statistical signiﬁcance
as accepted at p ≤ 0.05 and only signiﬁcant Treatment or
reatment  interactions are reported.eports 1 (2014) 699–706 701
3. Results
Fig. 1 shows camera lucida drawings of representative
neurons in the NAcc (Fig. 1A and B), DG (Fig. 1C and D), and
EC  (Fig. 1E and F) for both SAL- and MDMA-treated animals.
In  the NAcc, there were signiﬁcant effects of Treat-
ment (F(1,5) = 49.55, p < 0.001). The MDMA-treated animals
had  shorter dendritic lengths than the SAL-treated animals
(Fig.  2 top). Similarly, the MDMA-treated animals had fewer
dendritic  spines than the SAL-treated animals (F(1,5) = 9.06,
p  < 0.03 (Fig. 2 bottom)). No interaction for dendritic length
or  number of spines was observed.
In the DG the dendritic length was  shorter in the MDMA-
treated animals [Treatment, F(1,10.2) = 5.89, p < 0.04 (Fig. 3
top)],  whereas the number of spines was  increased
in the MDMA-treated animals compared with SAL-
treated animals [Treatment, F(1,4.2) = 9.97, p < 0.04 (Fig. 3
bottom)].  There was  a signiﬁcant interaction of Treat-
ment × Hemisphere (F(1,9) = 9.75, p < 0.02), however, irre-
spective of laterality, both hemispheres in the MDMA-
treated animals showed an increase in spine number
compared with the SAL-treated animals (not shown).
In  the EC there were signiﬁcant effects of Treatment
for both the basilar (F(1,5) = 18.1, p < 0.01) and apical
(F(1,5) = 13.97, p < 0.02) dendritic lengths. The MDMA-
treated animals had a reduction in dendritic length in both
the  basilar (Fig. 4A) and apical (Fig. 4B) branches com-
pared with SAL-treated animals. No other differences were
observed  for either the basilar or apical dendrites. Contrary
to  the differences in length, no differences were observed
for  the number of basilar (Fig. 4C) or apical (Fig. 4D) spines.
In  order to determine if the changes in dendritic length
were speciﬁc to the EC we  also examined the length of the
basilar  and apical branches in the frontal cortex. Unlike the
EC,  no differences in dendritic length were observed in the
frontal  cortex between MDMA-  and SAL-treated animals
(not  shown).
4.  Discussion
Exposure to MDMA  in neonatal rats leads to persistent
deﬁcits in the ability of the animals to perform similarly
to  control animals in various cognitive tests. Speciﬁcally,
deﬁcits are observed in spatial learning in the MWM  and
Barnes  maze, in the CWM  when run under bright light with
visible  distal cues and when run under infrared light with
no  visible cues (see [29]). Taken together, the data sug-
gest  that multiple regions of the brain are permanently
affected by MDMA  administration during the neonatal
period. Because of the known learning deﬁcits, we exam-
ined  several regions of interest, including the DG, NAcc, and
EC,  and show that long-term changes in neuronal archi-
tecture are present in these regions, regions important for
spatial  and egocentric learning and memory, and at an age
when  learning and memory deﬁcits have previously been
demonstrated.
While  mechanisms underlying the deﬁcits in learn-
ing and memory are unknown following neonatal MDMA
exposure, there are disruptions to multiple systems dur-
ing  and after the exposure period used here. For example,
we  have demonstrated that monoamines and especially
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cumben
ted neoFig. 1. Displayed are representative camera lucida tracings of nucleus ac
neurons  from Layer II of the entorhinal cortex (E and F) from animals trea
serotonin (5-HT) are depleted both during and follow-
ing  neonatal exposure to MDMA  [33–36]. This reduction
appears to ﬂuctuate over time but remains decreased
in the hippocampus through adulthood. Others have
demonstrated that exposure on P3 or P4 to agents that
cause  transient (para-chloroamphetamine) or permanent
(5,7-dihydroxytryptamine) depletions in 5-HT produces
reductions in spines without changes to the length of
the  neuron in the DG [56]. In contrast, in the present
experiment MDMA  administration increased the num-
ber  of spines in this region and decreased length. While
the  timing of the 5-HT depletions differs between these
studies by almost a week, there may  be factors other
than 5-HT that are affecting the MDMA-treated ani-
mals. MDMA  is not a purely serotonergic drug and can
affect  other neurotransmitter systems (Rothman et al.,
2001).  While dopamine levels are similar to controls
during the neonatal period of MDMA  administration, 3,4-
dihydroxyphenylacetic acid levels are changed [36,57],
suggesting an impact of MDMA  on dopamine metabolism.
In  adulthood, the animals treated as neonates with MDMA
show  decreases in dopamine in the prefrontal cortex and
striatum  [33], but see [27]. This change in dopamine may
be  important since we have shown that drugs that deplete
dopamine in the striatum in adulthood produce learning
and  memory deﬁcits in the CWM  [58,59]. Therefore, either
the  early changes in dopaminergic metabolism, or the later
decreases in dopamine, may  underlie learning deﬁcits in
the  CWM.  It should be noted that animals treated with
MDMA  from P11 to P20 also demonstrate hypoactivity
[27,60], further implicating dopamine as playing some role
in  cognitive deﬁcits produced by neonatal MDMA despite
the  fact that locomotor hypoactivity did not translate to
any  changes in swim speed during water maze testing.s pyramidal cells (A and B), dentate gyrus granular cells (C and D), and
natally with MDMA (A, C, and E) or SAL (B, D, and F).
We  have shown that neonatal rats treated with
methamphetamine from P11 to P20 have similar changes
in  the NAcc as those treated with MDMA  during this same
period;  that is, decreased dendritic length and spine den-
sity.  MA-treated and MDMA-treated animals both had an
∼16%  decrease in dendritic length in the NAcc, whereas
for number of spines, MA-treated animals had an ∼10%
decrease and the MDMA-treated animals had an ∼17%
decrease. In the DG, the two  drugs produced different
effects. For example, MA  only produced an ∼11% decrease
in  spines in the DG, whereas MDMA  produced an ∼45%
increase in spine density in this region and an ∼13%
decrease in length. Interestingly, MDMA-treated animals
tend  to have greater deﬁcits than MA-treated animals in the
MWM  (see [35,44] for comparison), a hippocampally mod-
ulated  behavior [37,61]. It should also be pointed out that
when  there were differences in the magnitude of an effect,
the  MDMA-treated animals appear to be more affected
than MA-treated animals. Animals that were exposed to
a  developmental stressor, maternal separation from P3 to
P21,  show increased spine density in the NAcc [62], lend-
ing  further support to the idea that the changes observed
here are biologically relevant. Neither drug had an effect
on  the frontal cortex. The EC was not examined following
methamphetamine exposure so a comparison between the
two  drugs cannot be made for this region. The EC is a region
important in egocentric learning and memory [41,63]. The
changes  in the EC may  be important for explaining the
learning deﬁcits in the CWM.  This is the ﬁrst study to our
knowledge to examine the EC of adult rats that were neona-
tally  exposed to a substituted amphetamine.
In adult animals, others have examined the change in
neuronal architecture following multiple days of MDMA
exposure. Whereas dendritic length in the NAcc was not
M.T. Williams et al. / Toxicology Reports 1 (2014) 699–706 703
Fig. 2. Total Sholl ring intersections in the NAcc (top) were decreased
in animals treated with MDMA  from P11 to P20 compared with saline
(SAL) animals (p < 0.001), and the number of spines (bottom) in this region
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Fig. 3. Total Sholl ring intersections in the dentate gyrus (top) were
decreased in animals treated with MDMA  from P11 to P20 compared with
saline (SAL) controls (p < 0.05), whereas the number of spines (bottom) inas also decreased in the MDMA-treated animals versus SAL animals
p < 0.05). *p < 0.05, ***p < 0.001.
hanged in adult MDMA-treated animals, the number of
pines  in the shell was increased [64]; a similar effect
as demonstrated in the dorsal striatum of adult ani-
als  that were administered MDMA  [65]. Furthermore,
dult animals have small changes in the prefrontal cor-
ex  for the composition of neurons and the number of
pines,  where the effect (i.e., increases or decreases) in
he  number of spines was dependent upon the branch-
ng of the dendrite [64]. Adult animals treated with
DMA  do not demonstrate egocentric route-based learn-
ng  and memory deﬁcits [59] or spatial learning deﬁcitsthis  region was  increased in the MDMA-treated animals versus SAL control
(p  < 0.05). *p < 0.05.
[66] as seen in animals treated neonatally (see [29]).
Rather, adult animals have deﬁcits in the CWM  only when
tested  with distal cues present but not when distal cues
are  removed [66,67]. While procedural differences may
account for the differences in effects between adult and
neonatal administration of MDMA,  the most important dif-
ference  appears to be the period of development when
animals are treated. Taken together, these data implicate
the  decreases in spine number and dendritic length as
factors  that may  contribute to the learning and memory
deﬁcits of animals treated neonatally with MDMA.  The
changes in morphology of Golgi-stained dendrites provide
704 M.T. Williams et al. / Toxicology Reports 1 (2014) 699–706
sed in b
ctively).Fig. 4. In the entorhinal cortex total Sholl ring intersections were decrea
animals compared with SAL-treated animals (p < 0.01 and p < 0.05, respe
(C)  or apical (D) projections. *p < 0.05, **p < 0.01.
initial evidence of altered synaptic connectivity [42]. In
support  of the idea that changes in dendritic spines are
affected by learning, in humans, the amount of education
a  person has correlates with dendritic length, such that
those  with more than a high school education have longer
dendritic lengths than those with only a high school edu-
cation,  and these both have longer dendritic lengths than
those  without a high school education [68]. In addition,
it  has been suggested that changes in dendritic synaptic
morphology are indicative of a particular disease state for
various  neurological disorders whether, for example, from
Alzheimer’s disease or drug addiction [69]. This is rele-
vant  to the present study since neonatal MDMA  exposure
produces allocentric and egocentric learning impairments
concurrently with decreases in dendritic length and spine
density  in brain regions implicated as important for these
two  types of learning and memory. The hippocampus, pre-
frontal  cortex, and entorhinal cortex all project to the NAcc
(for  review, [70]), and the changes observed in the NAccoth the basilar (A) and apical (B) dendrites in neonatally MDMA-treated
 No differences were noted in the number of spines in either the basilar
may  point to synaptic connectivity changes that impair
learning and memory in MDMA-treated animals.
There are limitations to this study. The animals were
examined in adulthood, therefore the developmental time
course  for these cytoarchitectural changes is unknown.
However, if the morphological changes precede the learn-
ing  and memory deﬁcits, then learning and memory
changes should appear very early and indeed we have
shown that allocentric and egocentric learning and mem-
ory  deﬁcits in MDMA-treated animals are present as early
as  P30 [28]. We used a single dose of MDMA  and only one
exposure period. We  used this dose because it consistently
produces learning and memory deﬁcits when given as a
single  or divided daily dose during the P11–20 exposure
period [31]. We  did not examine animals after learning and
memory  testing to determine if the morphological changes
could  be directly correlated to the learning and memory
deﬁcits; this must await further study now that morpho-
logical effects have been found.
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In conclusion, the results show that neonatal MDMA
xposure produces speciﬁc changes within the brain in
egions  that play essential roles in allocentric and ego-
entric learning and memory. It is recognized that Golgi
taining is suggestive for loss or increase of synaptic
onnectivity, and that further investigation is needed.
onetheless, the changes in spine densities and den-
ritic lengths suggest long-term synaptic reorganization
ollowing early MDMA  exposure during a period that is
pproximately analogous to late gestational human brain
evelopment.
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